Press Releases

SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that CoronaVac®, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life Sciences Co., Ltd., a subsidiary of the Company, was approved for emergency use under the World...

Thoma Bravo, a leading private equity investment firm focused on the software and technology-enabled services sector, announced that it has reached an agreement to acquire Greenphire, the global leader in financial lifecycle management software for clinical trials, from The...

Exscientia, the clinical stage, Artificial Intelligence (AI)-driven pharmatech company, announced that it has entered into a collaboration agreement with Bristol-Myers Squibb Company. This expanded collaboration has the potential to add to the Bristol Myers Squibb drug pipeline whilst enhancing...

Fulfilling our mission to deliver medicine to all means shipping pharma products to remote and infrastructurally challenging environments across the world. With our hybrid containers engineered and designed to safeguard cargo in the most extreme conditions, our solution is...

MedPharm Ltd, the world leader in formulation development and analytical services for topical and transdermal products, is thrilled to announce a £1.5M investment into the refurbishment and expansion of our 15,000 sq ft campus in Surrey, UK that will increase our UK laboratory...

Roche India and Cipla Limited announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India while a second batch will be made available by mid-June. In total they can potentially benefit 200,000...

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for active immunisation of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2. The Japanese Ministry of Health,...